| Gene Symbol | Bbs2 |
|---|---|
| Gene Name | Bardet-Biedl syndrome 2, transcript variant X1 |
| Entrez Gene ID | 101720407 |
For more information consult the page for NW_004624757.1 (Scaffold)
The following genes have been identified as possible homologs of the naked mole-rat gene and compared to it.
| Protein Percentage | 93.9% |
|---|---|
| CDS Percentage | 92.33% |
| Ka/Ks Ratio | 0.15488 (Ka = 0.0343, Ks = 0.2212) |
Bardet-Biedl syndrome 2
| Protein Percentage | 90.01% |
|---|---|
| CDS Percentage | 90.01% |
| Ka/Ks Ratio | 0.21751 (Ka = 0.0577, Ks = 0.2652) |
Bardet-Biedl syndrome 2 (human)
| Protein Percentage | 88.21% |
|---|---|
| CDS Percentage | 86.13% |
| Ka/Ks Ratio | 0.13446 (Ka = 0.0653, Ks = 0.4855) |
Bardet-Biedl syndrome 2 (Bbs2), mRNA
| Protein Percentage | 88.35% |
|---|---|
| CDS Percentage | 85.44% |
| Ka/Ks Ratio | 0.12258 (Ka = 0.0663, Ks = 0.5409) |
>XM_004847891.1 ATGTTGCTGCCTGTATTTACCCTGAAACTGCGCCACAAAATCAGCCCTCGCATGGTGGCCATAGGGCGCTACGACGGGACTCACCCGTGCCTGGCTGCCGCCACCCAAGCGGGCAAGGTTTTTATTCATAATCCTCATACACGAAGCCAGTTTTTCAGTGCATCCAGAATCTCCCAGAGCCCGCTGGAATCTGATGTTTCTCTTCTGAACATTAACCAGGCAGTCAGCTGCCTGACTGCAGGAGTACTGAGCCCTGAACTTGGCCATGATGCTCTTCTAGTGGGGACCCAGACTAATCTTTTGGCTTATGATGTCTACAATAATTCAGATTTGTTCTACAGAGAGGTAGCAGATGGGGCAAATGCCATTGTGCTGGGGATGTTGGGAGACGTGGCCTCCCCTCTTGCAATTATTGGTGGAAACTGTGTTCTGCAGGGTTTCGATCATGAAGGAAATGATCTCTTTTGGACGGTTACTGGAGACAGAGTTCATTCCTTGGCTTTGTGTGACTTTGACGGTGATGGGAAGAAAGAGCTTCTTGTTGGATCTGAGGATTTTGACATTCGCATTTTTAAAGAAGATGAGATTGTGACAGAAATGACAGAAACAGAGATAATCACCTCTCTGTGCCCCATGTATGGCAGCCGATTTGGGTATGCCCTTTCCAATGGCACAGTTGGAGTTTATGACAAAATGGCTCGATCCTGGAGAATTAAATCCAAAAATCATGCCATGAGCATTCATGCGTTTGACCTTAATTCTGATGGAGTGTGTGAACTGATAACTGGCTGGTCTAATGGGAAGGTTGATGCCCGAAGTGACCGAACTGGGGAGGTCATCTTTAAAGACAACTTTTCTTCTGCAATTGCTGGTGTGGTAGAGGGAGATTACCGAATGGATGGCCACATACAGCTAATCTGCTGCTCAGTGGATGGGGAAGTCCGGGGTTACCTGCCAGGCACAGCTGAGACAAGGGGAAGCCTCATGGATACCAGTATGGAGCAGGACCTGATCCGAGAACTGAGTCAGAAAAAGCAGAATCTGTTACTGGAACTCCGTAACTATGAGGAAAACGCCAAGGCTGAATTGAGTGGCCCATTGAATGAGGCTGACAGGCAAAGGGATGTAATACCAGCCAATACCAGGCTTCACACTATCCTCACAGTCAACCTGGGAAGCGAGACTCAAGCTGCACACACAGAGTTGTGCATTTCCACTTCAAATGACACCATCATTCGAGCAGTATTGATTTTTGCAGAGGGAATTTTTGTAGGTGAAAGCCACGTGGTACATCCCAGTGTTCACAACCTCTCCAGCTCTATCTGTGTCCCAATTATACCACCCAAAGATGTCCCTGTCGATCTGCACTTGAAAGCCCTTGTGGGTTACAGAAGCAGCACCCAGTTCCATGTATTTGAGTTGACAAGACAGCTGCCCCGATTCTCCATGTATGCGCTGACCAGCCCAATCTCTGCCAGTGAGCCCCTCAGTTATGTTAACTTCATCATAACAGAACGGGCACAGAGGATTGTTCTGTGGCTCAACCAGAACTTTCTGTTACCAGAAGACACCAATATTCAGAATGTTCCATTTCAAGCATGTTTCACATCATTACGGAATGGTGGCCACCTCTGCATAAAAATAAAACTTAGTGGAGAGATTACTATAAATACTGATGATATTGATTTGGCTGGTGACATCATCCAGTCAATGGCATCATTTTTTGCTATTGAAGACCTTCATGTAGAAGCAGATTTTCCTATCTACTTTGAGGAGTTACGAAAAGTGCTGATTAAGGTGGATGACTATCATTCAGTGCATCAGAAGCTCAGTGCTGAAATGGCTGATAATTCTAATGTAATCCGAAGTTTGTTGGTCCAAGCTGAGGATGCTCGCTTGATGAGGGACATGAAAACAATGAAGAATCGCTATATGGAACTCTATAACCTTAATAAAGACTTGCTAAATGGATATAAAATTCGCTGTAACAATCACACAGAACTATTAGGAAACCTTAAAGCAGTAAATCAGGCAATTCAACGGGCAGGTCGTCTGCGTGTTGGAAAACCAAAGAACCAGGTGATAACTGCTTGTCGGGATGCAATTCGAAGCAACAACATCAACACACTGTTCAGAATTATGCGGGTGGGGACAGCTCCTTCATAG
Bbs2 PREDICTED: Bardet-Biedl syndrome 2 protein isoform X1 [Heterocephalus glaber]
Length: 721 aa View alignments>XP_004847948.1 MLLPVFTLKLRHKISPRMVAIGRYDGTHPCLAAATQAGKVFIHNPHTRSQFFSASRISQSPLESDVSLLNINQAVSCLTAGVLSPELGHDALLVGTQTNLLAYDVYNNSDLFYREVADGANAIVLGMLGDVASPLAIIGGNCVLQGFDHEGNDLFWTVTGDRVHSLALCDFDGDGKKELLVGSEDFDIRIFKEDEIVTEMTETEIITSLCPMYGSRFGYALSNGTVGVYDKMARSWRIKSKNHAMSIHAFDLNSDGVCELITGWSNGKVDARSDRTGEVIFKDNFSSAIAGVVEGDYRMDGHIQLICCSVDGEVRGYLPGTAETRGSLMDTSMEQDLIRELSQKKQNLLLELRNYEENAKAELSGPLNEADRQRDVIPANTRLHTILTVNLGSETQAAHTELCISTSNDTIIRAVLIFAEGIFVGESHVVHPSVHNLSSSICVPIIPPKDVPVDLHLKALVGYRSSTQFHVFELTRQLPRFSMYALTSPISASEPLSYVNFIITERAQRIVLWLNQNFLLPEDTNIQNVPFQACFTSLRNGGHLCIKIKLSGEITINTDDIDLAGDIIQSMASFFAIEDLHVEADFPIYFEELRKVLIKVDDYHSVHQKLSAEMADNSNVIRSLLVQAEDARLMRDMKTMKNRYMELYNLNKDLLNGYKIRCNNHTELLGNLKAVNQAIQRAGRLRVGKPKNQVITACRDAIRSNNINTLFRIMRVGTAPS